Mortality and Clinical Outcomes among Patients with COVID-19 and Diabetes

Abstract

Background Diabetes mellitus (DM) is a decisive risk factor for severe illness in coronavirus disease 2019 (COVID-19). India is home to a large number of people with DM, and many of them were infected with COVID-19. It is critical to understand the impact of DM on mortality and other clinical outcomes of COVID-19 infection from this region. Aims The primary objective of our study was to analyze the mortality rate in people with DM infected with COVID-19. The secondary objectives were to assess the effect of various comorbidities on mortality and study the impact of DM on other clinical outcomes. Methods This is a retrospective study of COVID-19 infected patients admitted to a tertiary care hospital in north India in the early phase of the pandemic. Results Of the 1211 cases admitted, 19 were excluded because of incomplete data, and 1192 cases were finally considered for analysis. DM constituted 26.8% of total patients. The overall mortality rate was 6.1%, and the rate was 10.7% in the presence of diabetes (p < 0.01, OR 2.55). In univariate analysis, increased age, chronic kidney disease (CKD), coronary artery disease (CAD), stroke, and cancer were associated with mortality. On multiple logistic regression, the independent predictors of mortality were CAD, CKD, and cancer. Breathlessness and low SpO2 at presentation, extensive involvement in CXR, and elevated ANC/ALC ratio were also significantly associated with mortality. Conclusions The presence of comorbidities such as DM, hypertension, CAD, CKD, and cancer strongly predict the risk of mortality in COVID-19 infection. Early triaging and aggressive therapy of patients with these comorbidities can optimize clinical outcomes.

COVID-19 outcome among diabetic patients admitted in a tertiary care hospital: An observational study

“…Diabetes mellitus was found to negatively impact most of the outcomes analyzed in our study like hospital stay, ICU admission, and mortality were all adversely influenced by the presence of diabetes among covid-19 patients. In several studies and meta-analyses, also demonstrated consistent association with severe disease and adverse outcomes in COVID-19 infection among diabetes patients [22,23,24,25] . Clinical outcomes are dependent on many other factors including therapies received during hospitalization as well as associated comorbidities.…”

Development and validation of predictive models for COVID-19 outcomes in a safety-net hospital population

“…Patient age and past medical history like renal disease (CKD), cardiac disease (CAD) have extensively been described as factors influencing disease severity. 30 Laboratory data such as CRP and ferritin 31 are acute phase reactants and have also previously been associated with COVID-19 disease severity. The large and diverse population used in our work strongly supported these findings, and our interpretable LR model coefficients further numerically show their relative importance.…”

Association between COVID-19 and diabetes mellitus with intensive care unit care and need for mechanical ventilation: a retrospective cohort study of hospitalized patients in Southern Brazil

“…The coronavirus disease 2019 (COVID- 19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a global pandemic by the World Health Organization on March 11 th 2020, affecting millions of people worldwide 1 .…”